Active Ingredient(s): Altretamine
FDA Approved: * December 26, 1990
Pharm Company: * MGI PHARMA INC
Category: Cancer

Altretamine (trade name Hexalen), also called hexamethylmelamine, is an antineoplastic agent. It was approved by the U.S. FDA in 1990. Contents 1 Uses 2 Mechanism 3 Side effects 4 Interactions 5 See also 6 References Uses It is indicated for use as a single agent in the palliative treatment of patients with persistent or recurrent ovarian cancer following first-line therapy with cisplatin and/or alkylating agent-based combination.[1] It is not considered a first-line tr... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Hexalen 50 mg Oral Capsule
NDC: 58063-001
mgi Pharma, Inc.
Hexalen 50 mg Oral Capsule
NDC: 62856-001
Eisai Inc.